LBA
Letko, Brosseau & Associates’s TScan Therapeutics TCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $139K | Buy |
95,875
+18,775
| +24% | +$27.2K | ﹤0.01% | 88 |
|
|
2025
Q1 | $106K | Buy |
77,100
+40,900
| +113% | +$56.4K | ﹤0.01% | 84 |
|
|
2024
Q4 | $110K | Buy |
36,200
+15,500
| +75% | +$47.1K | ﹤0.01% | 96 |
|
|
2024
Q3 | $103K | Hold |
20,700
| – | – | ﹤0.01% | 98 |
|
|
2024
Q2 | $121K | Hold |
20,700
| – | – | ﹤0.01% | 100 |
|
|
2024
Q1 | $164K | Hold |
20,700
| – | – | ﹤0.01% | 97 |
|
|
2023
Q4 | $121K | Sell |
20,700
-11,700
| -36% | -$68.2K | ﹤0.01% | 91 |
|
|
2023
Q3 | $82.9K | Buy |
+32,400
| New | +$82.9K | ﹤0.01% | 94 |
|